
[
  
 {"id": "rn-001", "scope": ["RN"], "name": { "generic": "Quinidine", "brand": ["Quinaglute"] }, "class": "Sodium Channel Blocker - Class IA antidysrhythmic", "mechanism": "Blocks sodium channels in the cells of the cardiac conduction system", "indications": ["Acute treatment of ventricular cardiac arrhythmias"], "contraindications": ["Baseline prolonged QT interval, Hypersensitivity; Severe sinoatrial node dysfunction, aortic stenosis, or intraventricular blocks"], "interactions": ["Digoxin (toxicity); Beta-adrenergic blockers"], "education": ["Report excessive diarrhea"] },
{"id": "rn-002", "scope": ["RN"], "name": { "generic": "Procainamide", "brand": ["Procan"] }, "class": "Sodium Channel Blocker - Class IA antidysrhythmic", "mechanism": "Blocks sodium channels in the cells of the cardiac conduction system", "indications": ["Acute treatment of ventricular cardiac arrhythmias"], "contraindications": ["Baseline prolonged QT interval, systemic lupus erythematosus, hypersensitivity; Severe sinoatrial node dysfunction, aortic stenosis, or intraventricular blocks"], "interactions": ["Digoxin (toxicity); Beta-adrenergic blockers"], "education": ["Report hypotension, signs of lupus-like syndrome, or unusual bruising/bleeding"] }, 
{"id":"rn-003","scope":["RN"],"name":{"generic":"Lidocaine","brand":["Xylocaine"]},"class":"Sodium Channel Blocker - Class IB antidysrhythmic","mechanism":"Blocks sodium channels in the cells of the cardiac conduction system","indications":["Acute treatment of ventricular cardiac arrhythmias","Local and regional anesthesia"],"contraindications":["Wolff-Parkinson-White syndrome","Hypersensitivity","Severe sinoatrial node dysfunction, aortic stenosis, or intraventricular blocks"],"interactions":["Digoxin (toxicity)","Beta-adrenergic blockers"],"education":["Central nervous system toxicity"]},
{"id":"rn-004","scope":["RN"],"name":{"generic":"Mexiletine","brand":["Mexitil"]},"class":"Sodium Channel Blocker - Class IB antidysrhythmic","mechanism":"Blocks sodium channels in the cells of the cardiac conduction system","indications":["Acute treatment of ventricular cardiac arrhythmias"],"contraindications":["Hypersensitivity","Severe sinoatrial node dysfunction, aortic stenosis, or intraventricular blocks"],"interactions":["Digoxin (toxicity)","Beta-adrenergic blockers"],"education":["Report signs and symptoms of hepatic toxicity"]},
{"id":"rn-005","scope":["RN"],"name":{"generic":"Flecainide","brand":["Tambocor"]},"class":"Sodium Channel Blocker - Class IC antidysrhythmic","mechanism":"Blocks sodium channels in the cells of the cardiac conduction system","indications":["Acute treatment of ventricular cardiac arrhythmias"],"contraindications":["Structural heart disease","Hypersensitivity","Severe sinoatrial node dysfunction, aortic stenosis, or intraventricular blocks"],"interactions":["Digoxin (toxicity)","Beta-adrenergic blockers"],"education":["Risk of 1:1 AV conduction in atrial fibrillation or flutter"]},
{"id":"rn-006","scope":["RN"],"name":{"generic":"Propafenone","brand":["Rhythmol SR"]},"class":"Sodium Channel Blocker - Class IC antidysrhythmic","mechanism":"Blocks sodium channels in the cells of the cardiac conduction system","indications":["Acute treatment of ventricular cardiac arrhythmias"],"contraindications":["Structural heart disease","Hypersensitivity","Severe sinoatrial node dysfunction, aortic stenosis, or intraventricular blocks"],"interactions":["Digoxin (toxicity)","Beta-adrenergic blockers"],"education":["Report signs of infection due to agranulocytosis"]},
{"id":"rn-007","scope":["RN"],"name":{"generic":"Esmolol","brand":["Brevibloc"]},"class":"Beta-adrenergic blocker - Class II antidysrhythmic","mechanism":"Acts as a beta-1 receptor antagonist in cardiac tissue, slowing pacing from the sinoatrial node and conduction through the atrioventricular node","indications":["Short-term treatment of sinus tachycardia","Supraventricular tachycardia","Atrial fibrillation/flutter","Intraoperative and postoperative tachycardia and hypertension"],"contraindications":["Sinus bradycardia","Heart blocks","Cardiogenic shock","Overt cardiac failure","Sick sinus syndrome","Severe peripheral arterial circulatory disorders","Acute myocardial infarction","Hypotension"],"interactions":["Reserpine","Digoxin","Calcium channel blockers","CYP2D6 inhibitors","Alpha-adrenergic blockers","Ergot alkaloids"],"education":["Change positions slowly to avoid orthostatic hypotension","Do not abruptly stop medication"] },
{"id":"rn-008","scope":["RN"],"name":{"generic":"Metoprolol","brand":["Lopressor","Toprol XL"]},"class":"Beta-adrenergic blocker - Class II antidysrhythmic","mechanism":"Acts as a beta-1 receptor antagonist in cardiac tissue, slowing pacing from the sinoatrial node and conduction through the atrioventricular node","indications":["Rate control of atrial fibrillation/flutter","Angina","Heart failure","Hypertension","Myocardial infarction"],"contraindications":["Sinus bradycardia","Heart blocks","Cardiogenic shock","Overt cardiac failure","Sick sinus syndrome","Severe peripheral arterial circulatory disorders","Acute myocardial infarction","Hypotension"],"interactions":["Reserpine","Digoxin","Calcium channel blockers","CYP2D6 inhibitors","Alpha-adrenergic blockers","Ergot alkaloids"],"education":["Change positions slowly to avoid orthostatic hypotension","Do not abruptly stop medication"] },
{"id":"rn-009","scope":["RN"],"name":{"generic":"Atenolol","brand":["Tenormin"]},"class":"Beta-adrenergic blocker - Class II antidysrhythmic","mechanism":"Acts as a beta-1 receptor antagonist in cardiac tissue, slowing pacing from the sinoatrial node and conduction through the atrioventricular node","indications":["Rate control of atrial fibrillation/flutter","Angina","Heart failure","Hypertension","Myocardial infarction"],"contraindications":["Sinus bradycardia","Heart blocks","Cardiogenic shock","Overt cardiac failure","Sick sinus syndrome","Severe peripheral arterial circulatory disorders","Acute myocardial infarction","Hypotension"],"interactions":["Reserpine","Digoxin","Calcium channel blockers","CYP2D6 inhibitors","Alpha-adrenergic blockers","Ergot alkaloids"],"education":["Change positions slowly to avoid orthostatic hypotension","Do not abruptly stop medication"] },
{"id":"rn-010","scope":["RN"],"name":{"generic":"Propranolol","brand":["Inderal"]},"class":"Beta-adrenergic blocker - Class II antidysrhythmic","mechanism":"Acts as a beta-1 receptor antagonist in cardiac tissue, slowing pacing from the sinoatrial node and conduction through the atrioventricular node","indications":["Rate control of atrial fibrillation/flutter","Angina","Heart failure","Hypertension","Myocardial infarction"],"contraindications":["Sinus bradycardia","Heart blocks","Cardiogenic shock","Overt cardiac failure","Sick sinus syndrome","Severe peripheral arterial circulatory disorders","Acute myocardial infarction","Hypotension"],"interactions":["Reserpine","Digoxin","Calcium channel blockers","CYP2D6 inhibitors","Alpha-adrenergic blockers","Ergot alkaloids"],"education":["Change positions slowly to avoid orthostatic hypotension","Do not abruptly stop medication"] },
{"id":"rn-011","scope":["RN"],"name":{"generic":"Bisoprolol","brand":["Zebeta"]},"class":"Beta-adrenergic blocker - Class II antidysrhythmic","mechanism":"Acts as a beta-1 receptor antagonist in cardiac tissue, slowing pacing from the sinoatrial node and conduction through the atrioventricular node","indications":["Rate control of atrial fibrillation/flutter","Angina","Heart failure","Hypertension","Myocardial infarction"],"contraindications":["Sinus bradycardia","Heart blocks","Cardiogenic shock","Overt cardiac failure","Sick sinus syndrome","Severe peripheral arterial circulatory disorders","Acute myocardial infarction","Hypotension"],"interactions":["Reserpine","Digoxin","Calcium channel blockers","CYP2D6 inhibitors","Alpha-adrenergic blockers","Ergot alkaloids"],"education":["Change positions slowly to avoid orthostatic hypotension","Do not abruptly stop medication"] },
{"id": "rn-012", "scope": ["RN"], "name": { "generic": "Amiodarone", "brand": ["Pacerone"] }, "class": "Potassium channel blocker - Class III antidysrhythmic", "mechanism": "Blocks the potassium channels responsible for repolarization of the cell, leading to a prolonged action potential and prolonged refractoriness", "indications": ["Atrial fibrillation and atrial flutter"], "contraindications": ["Hypersensitivity", "Baseline QTc greater than 440 msec", "Severe renal impairment (creatinine clearance less than 20 mL/min)"], "interactions": ["Digoxin", "Warfarin", "Statins", "potassium-depleting diuretics", "drugs that prolong the QT interval"], "education": ["Symptoms of torsade de pointes", "symptoms of hyperthyroidism", "vision changes", "avoid grapefruits"] },
{"id": "rn-013", "scope": ["RN"], "name": { "generic": "Dronedarone", "brand": ["Multaq"] }, "class": "Potassium channel blocker - Class III antidysrhythmic", "mechanism": "Blocks the potassium channels responsible for repolarization of the cell, leading to a prolonged action potential and prolonged refractoriness", "indications": ["Atrial fibrillation and atrial flutter"], "contraindications": ["Hypersensitivity", "Baseline QTc greater than 440 msec", "Severe renal impairment (creatinine clearance less than 20 mL/min)"], "interactions": ["Digoxin", "calcium channel blockers", "statins"], "education": ["Symptoms of torsade de pointes", "symptoms of hyperthyroidism", "vision changes", "avoid grapefruits"] },
{"id": "rn-014", "scope": ["RN"], "name": { "generic": "Dofetilide", "brand": ["Tikosyn"] }, "class": "Potassium channel blocker - Class III antidysrhythmic", "mechanism": "Blocks the potassium channels responsible for repolarization of the cell, leading to a prolonged action potential and prolonged refractoriness", "indications": ["Atrial fibrillation and atrial flutter"], "contraindications": ["Hypersensitivity", "Baseline QTc greater than 440 msec", "Severe renal impairment (creatinine clearance less than 20 mL/min)"], "interactions": ["Potassium-depleting diuretics", "drugs that prolong the QT interval"], "education": ["Symptoms of torsade de pointes", "symptoms of hyperthyroidism", "vision changes", "avoid grapefruits"] },
{"id": "rn-015", "scope": ["RN"], "name": { "generic": "Ibutilide", "brand": ["Corvert"] }, "class": "Potassium channel blocker - Class III antidysrhythmic", "mechanism": "Blocks the potassium channels responsible for repolarization of the cell, leading to a prolonged action potential and prolonged refractoriness", "indications": ["Atrial fibrillation and atrial flutter"], "contraindications": ["Hypersensitivity", "Baseline QTc greater than 440 msec", "Severe renal impairment (creatinine clearance less than 20 mL/min)"], "interactions": ["Potassium-depleting diuretics", "drugs that prolong the QT interval"], "education": ["Symptoms of torsade de pointes", "symptoms of hyperthyroidism", "vision changes", "avoid grapefruits"] },
{"id": "rn-016", "scope": ["RN"], "name": { "generic": "Sotalol", "brand": ["Betapace"] }, "class": "Potassium channel blocker - Class III antidysrhythmic", "mechanism": "Blocks the potassium channels responsible for repolarization of the cell, leading to a prolonged action potential and prolonged refractoriness", "indications": ["Atrial fibrillation and atrial flutter"], "contraindications": ["Hypersensitivity", "Baseline QTc greater than 440 msec", "Severe renal impairment (creatinine clearance less than 20 mL/min)"], "interactions": ["Potassium-depleting diuretics", "drugs that prolong the QT interval"], "education": ["Symptoms of torsade de pointes", "symptoms of hyperthyroidism", "vision changes", "avoid grapefruits"] },
{"id": "rn-017", "scope": ["RN"], "name": { "generic": "Diltiazem", "brand": ["Cardizem"] }, "class": "Calcium Channel Blockers - Class IV antidysrhythmic", "mechanism": "Inhibits the calcium channel in cardiac tissue and blood vessels, leading to decreased conduction through the atrioventricular node and vasodilation", "indications": ["Angina", "Hypertension", "Atrial fibrillation/flutter"], "contraindications": ["Hypersensitivity", "Sick sinus syndrome (unless client has ventricular pacemaker)", "Hypotension", "Myocardial infarction", "Pulmonary congestion"], "interactions": ["Substrates or inhibitors of CYP3A4", "Beta-adrenergic blockers", "Benzodiazepines", "Clonidine", "Digoxin", "Statins"], "education": ["Symptoms of dysrhythmia", "Avoid grapefruit and alcohol"] },
{"id": "rn-018", "scope": ["RN"], "name": { "generic": "Verapamil", "brand": ["Calan SR"] }, "class": "Calcium Channel Blockers - Class IV antidysrhythmic", "mechanism": "Inhibits the calcium channel in cardiac tissue and blood vessels, leading to decreased conduction through the atrioventricular node and vasodilation", "indications": ["Angina", "Hypertension", "Atrial fibrillation/flutter"], "contraindications": ["Hypersensitivity", "Sick sinus syndrome (unless client has ventricular pacemaker)", "Hypotension", "Myocardial infarction", "Pulmonary congestion"], "interactions": ["Substrates or inhibitors of CYP3A4", "Beta-adrenergic blockers", "Benzodiazepines", "Clonidine", "Digoxin", "Statins"], "education": ["Symptoms of dysrhythmia", "Avoid grapefruit and alcohol"] },
{"id": "rn-019", "scope": ["RN"], "name": { "generic": "Atropine", "brand": ["AtroPen"] }, "class": "Antiarrhythmic - Class V, Anticholinergic", "mechanism": "Acetylcholine receptor antagonist, thus decreasing parasympathetic or vagal regulation of the heart rate", "indications": ["Symptomatic bradycardia"], "contraindications": ["Ventricular fibrillation"], "interactions": ["Potassium-sparing diuretics", "calcium", "amiodarone"], "education": ["Anticholinergic adverse effects"] },
{"id": "rn-020", "scope": ["RN"], "name": { "generic": "Digoxin", "brand": ["Lanoxin"] }, "class": "Antiarrhythmic - Class V, Cardiac glycoside", "mechanism": "Suppressing conduction through the AV node", "indications": ["Atrial fibrillation and atrial flutter"], "contraindications": ["Bradycardia", "Heart block", "Ventricular fibrillation"], "interactions": ["Potassium-sparing diuretics", "calcium", "amiodarone"], "education": ["Digoxin serum levels 0.5-2.0 ng/ml"] },
{"id": "rn-021", "scope": ["RN"], "name": { "generic": "Adenosine", "brand": ["Adenocard"] }, "class": "Antiarrhythmic - Class V", "mechanism": "Enhancing potassium efflux and suppressing calcium influx into the cells of the AV node", "indications": ["Paroxysmal supraventricular tachycardia"], "contraindications": ["Second- or third-degree AV block"], "interactions": ["Potassium-sparing diuretics", "calcium", "amiodarone"], "education": ["Asystole - sensation of heart stopping"] },
{"id": "rn-022", "scope": ["RN"], "name": { "generic": "Lactated Ringer's", "brand": ["LR"] }, "class": "Crystalloid - Isotonic", "mechanism": "Osmotic equilibrium, water does not enter or leave the cells", "indications": ["Rehydration"], "contraindications": ["Fluid overload", "Increased intracranial pressure"], "interactions": [], "education": [] },
{"id": "rn-023", "scope": ["RN"], "name": { "generic": "Normal Saline", "brand": ["NS"] }, "class": "Crystalloid - Isotonic", "mechanism": "Osmotic equilibrium, water does not enter or leave the cells", "indications": ["Rehydration", "Sodium repletion"], "contraindications": ["Fluid overload", "Increased intracranial pressure"], "interactions": [], "education": [] },
{"id": "rn-024", "scope": ["RN"], "name": { "generic": "5% dextrose in water", "brand": ["D5W"] }, "class": "Crystalloid - Isotonic", "mechanism": "Osmotic equilibrium, water does not enter or leave the cells", "indications": ["Rehydration", "Dextrose supplies calories"], "contraindications": ["Fluid overload", "Increased intracranial pressure"], "interactions": [], "education": [] },
{"id": "rn-025", "scope": ["RN"], "name": { "generic": "0.45% Normal saline", "brand": ["1/2 NS"] }, "class": "Crystalloid - Hypotonic", "mechanism": "Water moves into the cell or ICF compartment", "indications": ["Intracellular fluid volume deficit conditions"], "contraindications": ["Increased intracranial pressure"], "interactions": [], "education": [] },
{"id": "rn-026", "scope": ["RN"], "name": { "generic": "10% Dextrose in water", "brand": ["D10W"] }, "class": "Crystalloid - Hypertonic", "mechanism": "Pulls water from the interstitial space into the ECF causing cell shrinkage", "indications": ["Hyponatremia", "Cerebral edema", "Increased intracranial pressure"], "contraindications": ["Hypervolemia", "Pulmonary edema"], "interactions": [], "education": [] },
{"id": "rn-027", "scope": ["RN"], "name": { "generic": "Albumin", "brand": ["Albumin 5%", "Albumin 25%"] }, "class": "Colloid", "mechanism": "Solutions increase the colloidal oncotic pressure, drawing fluid from interstitial space into plasma", "indications": ["Volume loss"], "contraindications": ["Heart failure", "Anemia"], "interactions": [], "education": [] },
{"id": "rn-028", "scope": ["RN"], "name": { "generic": "Pyridostigmine bromide", "brand": ["Mestinon"] }, "class": "Acetylcholinesterase inhibitor", "mechanism": "Causes reversible inhibition of AChE within the synapse, allowing more ACh to bind to cholinergic receptors and prolonging its effects", "indications": ["Management of MG symptoms", "Reversal of competitive (nondepolarizing) neuromuscular blockade", "Prevention/treatment of urinary retention in postoperative clients"], "contraindications": ["Mechanical obstruction of the intestine or urinary tract"], "interactions": ["Succinylcholine", "Atropine"], "education": ["Signs of therapeutic failure and toxicity", "Change positions slowly"] },
{"id": "rn-029", "scope": ["RN"], "name": { "generic": "Neostigmine", "brand": ["Bloxiverz"] }, "class": "Acetylcholinesterase inhibitor", "mechanism": "Causes reversible inhibition of AChE within the synapse, allowing more ACh to bind to cholinergic receptors and prolonging its effects", "indications": ["Management of MG symptoms", "Reversal of competitive (nondepolarizing) neuromuscular blockade", "Prevention/treatment of urinary retention in postoperative clients"], "contraindications": ["Mechanical obstruction of the intestine or urinary tract"], "interactions": ["Succinylcholine", "Atropine"], "education": ["Signs of therapeutic failure and toxicity", "Change positions slowly"] },
{"id": "rn-030", "scope": ["RN"], "name": { "generic": "Donepezil", "brand": ["Aricept"] }, "class": "Acetylcholinesterase inhibitor", "mechanism": "Causes reversible inhibition of AChE", "indications": ["Mild to severe Alzheimer’s disease", "To treat overdoses of atropine and other centrally acting anticholinergic drugs"], "contraindications": ["Active peptic ulcer disease", "Active GI bleeding", "Urinary or intestinal obstruction", "Hypersensitivity"], "interactions": ["Anticholinergic agents", "NSAIDs", "Beta blockers", "Digoxin", "TCAs"], "education": ["Takes 15 days for drug to reach steady state"] },
{"id": "rn-031", "scope": ["RN"], "name": { "generic": "Donepezil transdermal", "brand": ["Adlarity"] }, "class": "Acetylcholinesterase inhibitor", "mechanism": "Causes reversible inhibition of AChE", "indications": ["Mild to severe Alzheimer’s disease"], "contraindications": ["Active peptic ulcer disease", "Active GI bleeding", "Urinary or intestinal obstruction", "Hypersensitivity"], "interactions": ["Anticholinergic agents", "NSAIDs", "Beta blockers", "Digoxin", "TCAs"], "education": ["Takes 15 days for drug to reach steady state"] },
{"id": "rn-032", "scope": ["RN"], "name": { "generic": "Galantamine", "brand": ["Razadyne"] }, "class": "Acetylcholinesterase inhibitor", "mechanism": "Causes reversible inhibition of AChE", "indications": ["Mild to severe Alzheimer’s disease"], "contraindications": ["Active peptic ulcer disease", "Active GI bleeding", "Urinary or intestinal obstruction", "Hypersensitivity"], "interactions": ["Anticholinergic agents", "NSAIDs", "Beta blockers", "Digoxin", "TCAs"], "education": ["Stevens-Johnson Syndrome"] },
{"id": "rn-033", "scope": ["RN"], "name": { "generic": "Rivastigmine", "brand": ["Exelon"] }, "class": "Acetylcholinesterase inhibitor", "mechanism": "Causes reversible inhibition of AChE", "indications": ["Mild to severe Alzheimer’s disease"], "contraindications": ["Active peptic ulcer disease", "Active GI bleeding", "Urinary or intestinal obstruction", "Hypersensitivity"], "interactions": ["No significant drug–drug interactions"], "education": ["Peripheral cholinergic effects"] },
{"id": "rn-034", "scope": ["RN"], "name": { "generic": "Memantine", "brand": ["Namenda"] }, "class": "NMDA receptor antagonist", "mechanism": "Binds to the NMDA receptor to prevent the central channel from opening, which regulates the influx of calcium and slows intracellular calcium accumulation", "indications": ["Moderate to severe dementia of the Alzheimer’s type"], "contraindications": ["Hypersensitivity"], "interactions": ["Carbonic anhydrase inhibitors", "Sodium bicarbonate", "Thiazide diuretics"], "education": ["Report severe nausea, vomiting, diarrhea, anorexia, weight loss, dehydration, or signs of GI bleeding"] },
{"id": "rn-035", "scope": ["RN"], "name": { "generic": "Benztropine mesylate", "brand": ["Cogentin"] }, "class": "Anticholinergic", "mechanism": "Exerts a direct inhibitory effect upon the parasympathetic nervous system by blocking muscarinic receptors in the striatum", "indications": ["As adjunct therapy for all forms of parkinsonism", "For control of extrapyramidal disorders (except tardive dyskinesia) caused by neuroleptic drugs"], "contraindications": ["Children ≤3 years of age", "Hypersensitivity"], "interactions": ["Antihistamines", "First-generation antipsychotics", "TCAs", "Cholinergic agonists (parasympathomimetics)"], "education": ["Report gastrointestinal complaints, fever, or heat intolerance"] },
{"id": "rn-036", "scope": ["RN"], "name": { "generic": "Trihexyphenidyl hydrochloride", "brand": ["Artane"] }, "class": "Anticholinergic", "mechanism": "Exerts a direct inhibitory effect upon the parasympathetic nervous system by blocking muscarinic receptors in the striatum", "indications": ["As adjunct therapy for all forms of parkinsonism", "For control of extrapyramidal disorders (except tardive dyskinesia) caused by neuroleptic drugs"], "contraindications": ["Children ≤3 years of age", "Hypersensitivity"], "interactions": ["Antihistamines", "First-generation antipsychotics", "TCAs", "Cholinergic agonists (parasympathomimetics)"], "education": ["Report gastrointestinal complaints, fever, or heat intolerance"] },
{"id": "rn-037", "scope": ["RN"], "name": { "generic": "Carbidopa/Levodopa", "brand": ["Sinemet"] }, "class": "Dopaminergic", "mechanism": "Taken up by dopaminergic nerve terminals in the striatum, converted into dopamine, then released to bind dopamine receptors", "indications": ["Reduces symptoms of Parkinson's Disease by increasing dopamine synthesis"], "contraindications": ["Narrow-angle glaucoma", "Hypersensitivity"], "interactions": ["Nonselective MAOIs", "Antipsychotics (first generation)", "Pyridoxine", "Antihypertensives", "Iron salts", "Dopamine receptor antagonists"], "education": ["Report involuntary movements of the face or mouth"] },
{"id":"rn-038","scope":["RN"],"name":{"generic":"Pramipexole","brand":["Mirapex"]},"class":"Dopamine agonist, nonergot derivative","mechanism":"Selectively binds to dopamine receptor subtype that activates CNS postsynaptic dopamine receptors in the striatum","indications":["Used alone in early-stage Parkinson disease","Combined with levodopa in advanced stages of Parkinson disease"],"contraindications":["None"],"interactions":["First-generation antipsychotic drugs","Dopamine antagonists","Serotonin receptor antagonists","Hormone replacement therapy","Drugs that can cause QT interval prolongation"],"education":["Assess for involuntary movements","Be aware of sudden onset of sleep while performing ADLs","Change positions slowly"] },
{"id":"rn-039","scope":["RN"],"name":{"generic":"Bromocriptine mesylate","brand":["Parlodel"]},"class":"Dopamine agonist, ergot derivative","mechanism":"Selectively binds to dopamine receptor subtype that activates CNS postsynaptic dopamine receptors in the striatum","indications":["Used alone in early-stage Parkinson disease","Combined with levodopa in advanced stages of Parkinson disease"],"contraindications":["None"],"interactions":["First-generation antipsychotic drugs","Dopamine antagonists","Serotonin receptor antagonists","Hormone replacement therapy","Drugs that can cause QT interval prolongation"],"education":["Assess for involuntary movements","Be aware of sudden onset of sleep while performing ADLs","Change positions slowly"] },
{"id":"rn-040","scope":["RN"],"name":{"generic":"Apomorphine hydrochloride","brand":["Apokyn"]},"class":"Dopamine agonist, nonergot derivative","mechanism":"Selectively binds to dopamine receptor subtype that activates CNS postsynaptic dopamine receptors in the striatum","indications":["Used alone in early-stage Parkinson disease","Combined with levodopa in advanced stages of Parkinson disease"],"contraindications":["None"],"interactions":["First-generation antipsychotic drugs","Dopamine antagonists","Serotonin receptor antagonists","Hormone replacement therapy","Drugs that can cause QT interval prolongation"],"education":["Assess for involuntary movements","Be aware of sudden onset of sleep while performing ADLs","Change positions slowly","Routine EKG monitoring for prolonged QT interval"] },
{"id":"rn-041","scope":["RN"],"name":{"generic":"Ropinirole","brand":["Requip"]},"class":"Dopamine agonist, nonergot derivative","mechanism":"Selectively binds to dopamine receptor subtype that activates CNS postsynaptic dopamine receptors in the striatum","indications":["Used alone in early-stage Parkinson disease","Combined with levodopa in advanced stages of Parkinson disease"],"contraindications":["None"],"interactions":["First-generation antipsychotic drugs","Dopamine antagonists","Serotonin receptor antagonists","Hormone replacement therapy","Drugs that can cause QT interval prolongation"],"education":["Assess for involuntary movements","Be aware of sudden onset of sleep while performing ADLs","Change positions slowly"] },
{"id":"rn-042","scope":["RN"],"name":{"generic":"Rotigotine","brand":["Neupro"]},"class":"Dopamine agonist, nonergot derivative","mechanism":"Selectively binds to dopamine receptor subtype that activates CNS postsynaptic dopamine receptors in the striatum","indications":["Used alone in early-stage Parkinson disease","Combined with levodopa in advanced stages of Parkinson disease"],"contraindications":["None"],"interactions":["First-generation antipsychotic drugs","Dopamine antagonists","Serotonin receptor antagonists","Hormone replacement therapy","Drugs that can cause QT interval prolongation"],"education":["Assess for involuntary movements","Be aware of sudden onset of sleep while performing ADLs","Change positions slowly"] },
{"id":"rn-043","scope":["RN"],"name":{"generic":"Selegiline hydrochloride","brand":["Eldepryl"]},"class":"MAO-B inhibitor","mechanism":"Selectively and irreversibly inhibits MAO-B","indications":["Adjunctive therapy of idiopathic Parkinson disease with levodopa-carbidopa when response has decreased","Helps decrease fluctuations in motor control"],"contraindications":["Hypersensitivity"],"interactions":["Morphine","Meperidine","Tramadol","SSRIs","TCAs","Sympathomimetics"],"education":["Report severe headaches","Monitor for signs and symptoms of liver damage","Risk for insomnia"] },
{"id":"rn-044","scope":["RN"],"name":{"generic":"Safinamide","brand":["Xadago"]},"class":"MAO-B inhibitor","mechanism":"Selectively and irreversibly inhibits MAO-B","indications":["Adjunctive therapy of idiopathic Parkinson disease with levodopa-carbidopa when response has decreased","Helps decrease fluctuations in motor control"],"contraindications":["Hypersensitivity"],"interactions":["Morphine","Meperidine","Tramadol","SSRIs","TCAs","Sympathomimetics"],"education":["Report severe headaches","Monitor for signs and symptoms of liver damage"] },
{"id":"rn-045","scope":["RN"],"name":{"generic":"Rasagiline","brand":["Azilect"]},"class":"MAO-B inhibitor","mechanism":"Selectively and irreversibly inhibits MAO-B","indications":["Adjunctive therapy of idiopathic Parkinson disease with levodopa-carbidopa when response has decreased","Helps decrease fluctuations in motor control"],"contraindications":["Hypersensitivity"],"interactions":["Morphine","Meperidine","Tramadol","SSRIs","TCAs","Sympathomimetics"],"education":["Report severe headaches","Monitor for signs and symptoms of liver damage"] },
{"id":"rn-046","scope":["RN"],"name":{"generic":"Entacapone","brand":["Comtan"]},"class":"COMT inhibitor","mechanism":"Prevents destruction of levodopa in the intestine and peripheral tissues and decreases production of levodopa metabolites that compete for transport across the blood–brain barrier","indications":["Adjunctive to levodopa in the treatment of Parkinson disease"],"contraindications":["Psychotic disorders with risk of symptom exacerbation"],"interactions":["Methyldopa","Dobutamine","Isoproterenol","Nonselective MAOIs"],"education":["Monitor for liver disease","Change positions slowly"] },
{"id":"rn-047","scope":["RN"],"name":{"generic":"Tolcapone","brand":["Tasmar"]},"class":"COMT inhibitor","mechanism":"Prevents destruction of levodopa in the intestine and peripheral tissues and decreases production of levodopa metabolites that compete for transport across the blood–brain barrier","indications":["Adjunctive to levodopa in the treatment of Parkinson disease"],"contraindications":["Psychotic disorders with risk of symptom exacerbation"],"interactions":["Methyldopa","Dobutamine","Isoproterenol","Nonselective MAOIs"],"education":["Monitor for liver disease","Change positions slowly"] }, 
{"id":"rn-048","scope":["RN"],"name":{"generic":"Amantadine","brand":["Gocovri"]},"class":"Dopamine antagonist","mechanism":"Increases release of dopamine from vesicles in presynaptic neurons, blocks reuptake of dopamine into presynaptic neurons, and blocks cholinergic, NMDA, and glutamate receptors","indications":["Reduction of Parkinson disease symptoms","Management of levodopa-induced dyskinesia"],"contraindications":["May exacerbate heart failure","Lowered seizure threshold","Angle-closure glaucoma"],"interactions":["CNS stimulants","Anticholinergics","Quinidine","Live vaccines"],"education":["High risk for suicide","Light sensitivity"] },
{"id":"rn-049","scope":["RN"],"name":{"generic":"Interferon beta-1a","brand":["Avonex"]},"class":"Interferons","mechanism":"Enhances suppressor T-cell activity, reduces pro-inflammatory cytokine production, down-regulates antigen presentation, and inhibits lymphocyte trafficking across the blood–brain barrier","indications":["Relapsing forms of multiple sclerosis"],"contraindications":["Hypersensitivity to interferon beta","Hypersensitivity to albumin or any drug ingredient"],"interactions":["Hypersensitivity to albumin, mannitol, or E. coli–derived products","Chemotherapeutic agents","Bone marrow suppressing drugs","Live vaccines"],"education":["Rotate injection sites","Monitor for symptoms of hypo- and hyperthyroidism","Expect flu-like symptoms on day of injection"] },
{"id":"rn-050","scope":["RN"],"name":{"generic":"Interferon beta-1b","brand":["Betaseron"]},"class":"Interferons","mechanism":"Enhances suppressor T-cell activity, reduces pro-inflammatory cytokine production, down-regulates antigen presentation, and inhibits lymphocyte trafficking across the blood–brain barrier","indications":["Relapsing forms of multiple sclerosis"],"contraindications":["Hypersensitivity to interferon beta","Hypersensitivity to albumin or any drug ingredient"],"interactions":["Hypersensitivity to albumin, mannitol, or E. coli–derived products","Chemotherapeutic agents","Bone marrow suppressing drugs","Live vaccines"],"education":["Rotate injection sites","Monitor for symptoms of hypo- and hyperthyroidism","Expect flu-like symptoms on day of injection"] },
{"id":"rn-051","scope":["RN"],"name":{"generic":"Teriflunomide","brand":["Aubagio"]},"class":"Immunomodulator","mechanism":"Inhibits dihydroorotate dehydrogenase, a mitochondrial enzyme involved in pyrimidine synthesis","indications":["Relapsing forms of multiple sclerosis"],"contraindications":["Hypersensitivity","Pregnancy or breastfeeding","Active acute or long-term infections","Severe hepatic impairment","Immunocompromised state"],"interactions":["Other immunosuppressive drugs","Other hepatotoxic drugs","Oral contraceptives","Warfarin","HMG-CoA reductase inhibitors","Live vaccines"],"education":["Use effective contraceptive barrier","Rule out latent TB before initiating therapy","Monitor for signs and symptoms of liver injury"] },
{"id":"rn-052","scope":["RN"],"name":{"generic":"Monomethyl fumarate","brand":["Bafiertam"]},"class":"Immunomodulator","mechanism":"Inhibits dihydroorotate dehydrogenase, a mitochondrial enzyme involved in pyrimidine synthesis","indications":["Relapsing forms of multiple sclerosis"],"contraindications":["Hypersensitivity","Pregnancy or breastfeeding","Active acute or long-term infections","Severe hepatic impairment","Immunocompromised state"],"interactions":["Other immunosuppressive drugs","Other hepatotoxic drugs","Oral contraceptives","Warfarin","HMG-CoA reductase inhibitors","Live vaccines"],"education":["Use effective contraceptive barrier","Rule out latent TB before initiating therapy","Monitor for signs and symptoms of liver injury"] },
{"id":"rn-053","scope":["RN"],"name":{"generic":"Glatiramer acetate","brand":["Copaxone"]},"class":"Immunomodulator","mechanism":"Inhibits dihydroorotate dehydrogenase, a mitochondrial enzyme involved in pyrimidine synthesis","indications":["Relapsing forms of multiple sclerosis"],"contraindications":["Hypersensitivity","Pregnancy or breastfeeding","Active acute or long-term infections","Severe hepatic impairment","Immunocompromised state"],"interactions":["Other immunosuppressive drugs","Other hepatotoxic drugs","Oral contraceptives","Warfarin","HMG-CoA reductase inhibitors","Live vaccines"],"education":["Use effective contraceptive barrier","Rule out latent TB before initiating therapy","Monitor for signs and symptoms of liver injury"] },
{"id":"rn-054","scope":["RN"],"name":{"generic":"Alemtuzumab","brand":["Lemtrada"]},"class":"Monoclonal antibody","mechanism":"Targets CD52 protein on lymphocytes, natural killer cells, monocytes, and macrophages, leading to antibody-dependent cellular cytolysis","indications":["Reduces frequency and severity of relapses in relapsing-remitting and secondary progressive multiple sclerosis"],"contraindications":["Hypersensitivity or anaphylaxis to alemtuzumab","HIV infection","Active infection","Pregnancy","Active hepatitis B","History of life-threatening infusion reactions"],"interactions":["Antineoplastics","Immunosuppressive or immunomodulatory drugs"],"education":["Monitor for post-infusion reactions","Increased risk of malignancies","Report signs and symptoms of hypo- or hyperthyroidism"] },
{"id":"rn-055","scope":["RN"],"name":{"generic":"Ocrelizumab","brand":["Ocrevus"]},"class":"Monoclonal antibody","mechanism":"Targets CD52 protein on lymphocytes, natural killer cells, monocytes, and macrophages, leading to antibody-dependent cellular cytolysis","indications":["Reduces frequency and severity of relapses in relapsing-remitting and secondary progressive multiple sclerosis"],"contraindications":["Hypersensitivity or anaphylaxis to monoclonal antibodies","HIV infection","Active infection","Pregnancy","Active hepatitis B","History of life-threatening infusion reactions"],"interactions":["Antineoplastics","Immunosuppressive or immunomodulatory drugs"],"education":["Monitor for post-infusion reactions","Increased risk of malignancies","Report signs and symptoms of hypo- or hyperthyroidism"] },
{"id":"rn-056","scope":["RN"],"name":{"generic":"Natalizumab","brand":["Tysabri"]},"class":"Monoclonal antibody","mechanism":"Targets CD52 protein on lymphocytes, natural killer cells, monocytes, and macrophages, leading to antibody-dependent cellular cytolysis","indications":["Reduces frequency and severity of relapses in relapsing-remitting and secondary progressive multiple sclerosis"],"contraindications":["Hypersensitivity or anaphylaxis to natalizumab","HIV infection","Active infection","Pregnancy","Active hepatitis B","History of life-threatening infusion reactions"],"interactions":["Antineoplastics","Immunosuppressive or immunomodulatory drugs"],"education":["Monitor for post-infusion reactions","Increased risk of malignancies","Report signs and symptoms of hypo- or hyperthyroidism"] },
{"id":"rn-057","scope":["RN"],"name":{"generic":"Siponimod fumaric acid","brand":["Mayzent"]},"class":"S1P receptor modulator","mechanism":"Modulates immune cell trafficking by sequestering autoreactive lymphocytes in lymphoid organs, reducing their recirculation and infiltration into the CNS","indications":["Reduces relapse in relapsing-remitting and secondary progressive multiple sclerosis","Reduces symptoms in clinically isolated syndrome"],"contraindications":["CYP2C9 genotype restrictions","In the past 6 months: unstable angina, myocardial infarction, transient ischemic attack/stroke, Class III/IV heart failure, Mobitz II or third-degree heart block"],"interactions":["Hepatotoxic drugs","Class Ia or Class III antiarrhythmic drugs","Antineoplastics","Immunosuppressive or immune-modulating therapies","Live vaccines","Drugs that slow heart rate or atrioventricular conduction"],"education":["Increased risk for malignancies","Monitor for liver injury","Monitor for neurological changes"] },
{"id":"rn-058","scope":["RN"],"name":{"generic":"Baclofen","brand":["Lioresal"]},"class":"Muscle relaxant - centrally acting","mechanism":"Inhibits GABA receptors in the spinal cord, restricts calcium influx, reduces presynaptic neurotransmitter release in excitatory spinal pathways, decreasing nerve impulse transmission to skeletal muscles and reducing spasticity","indications":["Reversible muscle spasticity associated with neuromuscular diseases such as multiple sclerosis and spinal cord injuries"],"contraindications":["May exacerbate symptoms of heart failure"],"interactions":["Agents causing CNS depression","Alcohol","Anticholinergic agents"],"education":["Monitor for CNS depression of parasympathetic reflexes"] },
{"id":"rn-059","scope":["RN"],"name":{"generic":"Dantrolene sodium","brand":["Dantrium"]},"class":"Muscle relaxant - peripherally acting","mechanism":"Inhibits release of calcium from the sarcoplasmic reticulum within skeletal muscle cells, reducing muscle contraction","indications":["Reversible muscle spasticity associated with neuromuscular diseases such as multiple sclerosis and spinal cord injuries","Treatment and prevention of malignant hyperthermia"],"contraindications":["May exacerbate symptoms of heart failure"],"interactions":["Agents causing CNS depression","Alcohol","Anticholinergic agents"],"education":["Monitor for CNS depression of parasympathetic reflexes"] },
{"id":"rn-060","scope":["RN"],"name":{"generic":"Gabapentin","brand":["Neurontin"]},"class":"Gamma-Aminobutyric Acid Structural Analog","mechanism":"Binds with calcium channels on nerve terminals, inhibiting neuronal calcium influx","indications":["Focal seizures","Neuropathic pain"],"contraindications":["Hypersensitivity"],"interactions":["CNS depressants","Alcohol","ACE inhibitors","Thiazolidinediones"],"education":["Use as adjunct to antiseizure medication","Monitor for CNS depression","Risk for dependence"] },
{"id":"rn-061","scope":["RN"],"name":{"generic":"Pregabalin","brand":["Lyrica"]},"class":"Gamma-Aminobutyric Acid Structural Analog","mechanism":"Binds with calcium channels on nerve terminals, inhibiting neuronal calcium influx","indications":["Focal seizures","Neuropathic pain"],"contraindications":["Hypersensitivity"],"interactions":["CNS depressants","Alcohol","ACE inhibitors","Thiazolidinediones"],"education":["Use as adjunct to antiseizure medication","Monitor for CNS depression","Risk for dependence"] },
{"id":"rn-062","scope":["RN"],"name":{"generic":"Phenytoin","brand":["Dilantin"]},"class":"Anticonvulsant - Hydantoin","mechanism":"Decreases abnormal electrical activity in the brain through voltage-dependent blockade of membrane sodium channels responsible for action potentials","indications":["Treatment of tonic-clonic and psychomotor seizures","Prevention and treatment of seizures during neurosurgery"],"contraindications":["Hypersensitivity","Prior history of acute hepatotoxicity","Bradycardia or heart block"],"interactions":["Azoles","Antineoplastic agents","Delavirdine","Neuromuscular blocking agents","Warfarin","Calcium channel blockers","Antilipemic agents","Antacids"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-063","scope":["RN"],"name":{"generic":"Phenobarbital","brand":["Luminal"]},"class":"Barbiturate","mechanism":"Inhibits the central nervous system by enhancing GABA activity","indications":["Seizures","Benzodiazepine withdrawal"],"contraindications":["Hypersensitivity","Hepatic failure","Respiratory disease"],"interactions":["Anticoagulants","Corticosteroids","Griseofulvin","Doxycycline","Phenytoin","Sodium valproate","Valproic acid","MAOIs","Estradiol, estrone, progesterone, and other steroidal hormones","Other CNS depressants"],"education":["Routine laboratory testing required during titration"] }, 
{"id":"rn-064","scope":["RN"],"name":{"generic":"Ethosuximide","brand":["Zarontin"]},"class":"Anticonvulsant - Succinate","mechanism":"Blocks calcium channels in the brain","indications":["Seizures"],"contraindications":["Hypersensitivity"],"interactions":["Phenytoin","Valproic acid"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-065","scope":["RN"],"name":{"generic":"Clonazepam","brand":["Klonopin"]},"class":"Benzodiazepine","mechanism":"Binds to benzodiazepine receptors on postsynaptic GABA-A ligand-gated chloride channel neurons in the CNS","indications":["Seizures","Short-term relief of severe anxiety"],"contraindications":["Hypersensitivity","Acute narrow-angle glaucoma","Respiratory insufficiency","Pregnancy/breastfeeding"],"interactions":["Opioids","Scopolamine","Probenecid"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-066","scope":["RN"],"name":{"generic":"Clorazepate","brand":["Tranxene"]},"class":"Benzodiazepine","mechanism":"Binds to benzodiazepine receptors on postsynaptic GABA-A ligand-gated chloride channel neurons in the CNS","indications":["Seizures","Short-term relief of severe anxiety"],"contraindications":["Hypersensitivity","Acute narrow-angle glaucoma","Respiratory insufficiency","Pregnancy/breastfeeding"],"interactions":["Opioids","Scopolamine","Probenecid"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-067","scope":["RN"],"name":{"generic":"Diazepam","brand":["Valium"]},"class":"Benzodiazepine","mechanism":"Binds to benzodiazepine receptors on postsynaptic GABA-A ligand-gated chloride channel neurons in the CNS","indications":["Seizures","Short-term relief of severe anxiety"],"contraindications":["Hypersensitivity","Acute narrow-angle glaucoma","Respiratory insufficiency","Pregnancy/breastfeeding"],"interactions":["Opioids","Scopolamine","Probenecid"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-068","scope":["RN"],"name":{"generic":"Lorazepam","brand":["Ativan"]},"class":"Benzodiazepine","mechanism":"Binds to benzodiazepine receptors on postsynaptic GABA-A ligand-gated chloride channel neurons in the CNS","indications":["Seizures","Short-term relief of severe anxiety"],"contraindications":["Hypersensitivity","Acute narrow-angle glaucoma","Respiratory insufficiency","Pregnancy/breastfeeding"],"interactions":["Opioids","Scopolamine","Probenecid"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-069","scope":["RN"],"name":{"generic":"Carbamazepine","brand":["Tegretol"]},"class":"Anticonvulsant - Iminostilbenes","mechanism":"Inhibits neuronal excitability by enhancing GABA activity","indications":["Seizures"],"contraindications":["Hypersensitivity","Bone marrow suppression"],"interactions":["TCAs","MAOIs","Nefazodone","Delavirdine"],"education":["Routine laboratory testing required during titration","Monitor for risk of toxic epidermal necrolysis and Stevens-Johnson syndrome"] },
{"id":"rn-070","scope":["RN"],"name":{"generic":"Valproic acid","brand":["Depakote"]},"class":"Anticonvulsant - Valproates","mechanism":"Acts on GABA levels in the CNS by blocking voltage-gated sodium, potassium, and calcium channels, decreasing neuronal excitability","indications":["Seizures","Bipolar disorder"],"contraindications":["Hypersensitivity","Hepatic insufficiency","Bone marrow depression","Pregnancy"],"interactions":["Amitriptyline/nortriptyline","Carbamazepine","Clonazepam","Diazepam","Ethosuximide","Lamotrigine","Phenobarbital","Phenytoin","Propofol","Rufinamide","Tolbutamide","Warfarin","Zidovudine"],"education":["Routine laboratory testing required during titration","Monitor for pancreatitis","Monitor for abnormal bleeding and clotting times"] }, 
{"id":"rn-071","scope":["RN"],"name":{"generic":"Levetiracetam","brand":["Keppra"]},"class":"Anticonvulsant - Pyrrolidine","mechanism":"Binds to synaptic vesicle protein 2A (SV2A), decreasing the rate of vesicle neurotransmitter release in a calcium-dependent manner","indications":["Seizures"],"contraindications":["Hypersensitivity","Renal impairment"],"interactions":["Baclofen","Melatonin","Opioids","Trazodone"],"education":["Routine laboratory testing required during titration","Monitor for life-threatening behavioral manifestations and psychotic symptoms"] },
{"id":"rn-072","scope":["RN"],"name":{"generic":"Lamotrigine","brand":["Lamictal"]},"class":"Anticonvulsant - phenyltriazine","mechanism":"Blocks voltage-gated sodium ion channels and inhibits presynaptic glutamate and aspartate release","indications":["Seizures","Bipolar disorder"],"contraindications":["Hypersensitivity"],"interactions":["Valproate","Oral contraceptives","Sodium channel blockers"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-073","scope":["RN"],"name":{"generic":"Topiramate","brand":["Topamax"]},"class":"Anticonvulsant","mechanism":"Stimulates GABA-A receptor activity at non-benzodiazepine receptor sites and reduces glutamate activity","indications":["Partial or generalized seizures"],"contraindications":["Hypersensitivity"],"interactions":["Carbonic anhydrase inhibitors","CNS depressants","Digoxin"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-074","scope":["RN"],"name":{"generic":"Lacosamide","brand":["Vimpat"]},"class":"Anticonvulsant","mechanism":"Blocks voltage-gated sodium ion channels and decreases brain activity","indications":["Partial seizures"],"contraindications":["Hypersensitivity","Second- and third-degree atrioventricular (AV) block"],"interactions":["None"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-075","scope":["RN"],"name":{"generic":"Zonisamide","brand":["Zonegran"]},"class":"Anticonvulsant - Sulfonamide","mechanism":"Blocks voltage-gated sodium ion channels and inhibits presynaptic glutamate and aspartate release","indications":["Adjunctive therapy for partial seizures"],"contraindications":["Hypersensitivity"],"interactions":["CNS depressants"],"education":["Routine laboratory testing required during titration"] },
{"id":"rn-076","scope":["RN"],"name":{"generic":"Eletriptan","brand":["Relpax"]},"class":"Serotonin agonist","mechanism":"Selectively binds to serotonin receptors 5-HT1B and 5-HT1D, inducing vasoconstriction of cranial arteries","indications":["To treat migraine headaches","To treat cluster headaches"],"contraindications":["Hypersensitivity","Ischemic coronary disease","Stroke","Peripheral vascular disease","Uncontrolled hypertension","Pregnancy"],"interactions":["Ergot-containing drugs","MAOIs","SSRIs","TCAs","Serotonin and norepinephrine reuptake inhibitors","Tricyclic antidepressants"],"education":["Monitor response to medication","Identify triggers"] },
{"id":"rn-077","scope":["RN"],"name":{"generic":"Rizatriptan","brand":["Maxalt"]},"class":"Serotonin agonist","mechanism":"Selectively binds to serotonin receptors 5-HT1B and 5-HT1D, inducing vasoconstriction of cranial arteries","indications":["To treat migraine headaches","To treat cluster headaches"],"contraindications":["Hypersensitivity","Ischemic coronary disease","Stroke","Peripheral vascular disease","Uncontrolled hypertension","Pregnancy"],"interactions":["Ergot-containing drugs","MAOIs","SSRIs","TCAs","Serotonin and norepinephrine reuptake inhibitors","Tricyclic antidepressants"],"education":["Monitor response to medication","Identify triggers"] },
{"id":"rn-078","scope":["RN"],"name":{"generic":"Sumatriptan","brand":["Imitrex"]},"class":"Serotonin agonist","mechanism":"Selectively binds to serotonin receptors 5-HT1B and 5-HT1D, inducing vasoconstriction of cranial arteries","indications":["To treat migraine headaches","To treat cluster headaches"],"contraindications":["Hypersensitivity","Ischemic coronary disease","Stroke","Peripheral vascular disease","Uncontrolled hypertension","Pregnancy"],"interactions":["Ergot-containing drugs","MAOIs","SSRIs","TCAs","Serotonin and norepinephrine reuptake inhibitors","Tricyclic antidepressants"],"education":["Monitor response to medication","Identify triggers","Risk of adverse thrombotic events"] },
{"id":"rn-079","scope":["RN"],"name":{"generic":"Zolmitriptan","brand":["Zomig"]},"class":"Serotonin agonist","mechanism":"Selectively binds to serotonin receptors 5-HT1B and 5-HT1D, inducing vasoconstriction of cranial arteries","indications":["To treat migraine headaches","To treat cluster headaches"],"contraindications":["Hypersensitivity","Ischemic coronary disease","Stroke","Peripheral vascular disease","Uncontrolled hypertension","Pregnancy"],"interactions":["Ergot-containing drugs","MAOIs","SSRIs","TCAs","Serotonin and norepinephrine reuptake inhibitors","Tricyclic antidepressants"],"education":["Monitor response to medication","Identify triggers"] },
{"id":"rn-080","scope":["RN"],"name":{"generic":"Ergotamine tartrate","brand":["Cafergot"]},"class":"Alpha-adrenergic blocker - Ergot alkaloid","mechanism":"Inhibits norepinephrine and directly stimulates vascular smooth muscle, causing vasoconstriction","indications":["Migraine and vascular headaches"],"contraindications":["Hypersensitivity","Vasoconstrictive conditions","Renal insufficiency","Hepatic insufficiency","Myocardial ischemia or infarction"],"interactions":["Ritonavir","Indinavir","Erythromycin","Clarithromycin","Troleandomycin"],"education":["Monitor response to medication","Identify triggers"] },
{"id":"rn-081","scope":["RN"],"name":{"generic":"Lasmiditan","brand":["Reyvow"]},"class":"Selective serotonin receptor agonist","mechanism":"Decreases the release of neuropeptides and glutamate, inhibiting neuronal firing","indications":["To treat migraine and cluster headaches"],"contraindications":["Hypersensitivity"],"interactions":["SSRIs","Serotonin and norepinephrine reuptake inhibitors","TCAs"],"education":["Monitor response to medication","Identify triggers"] },
{"id":"rn-082","scope":["RN"],"name":{"generic":"Rimegepant","brand":["Nurtec"]},"class":"CGRP receptor antagonist","mechanism":"Binds to CGRP receptors, decreasing inflammation in the meninges of the brain","indications":["To treat migraine headaches"],"contraindications":["Hypersensitivity"],"interactions":["Ritonavir","Indinavir","Amiodarone","Cyclosporine","Quinidine"],"education":["Monitor response to medication","Identify triggers"] },
{"id":"rn-083","scope":["RN"],"name":{"generic":"Acetazolamide","brand":["Diamox"]},"class":"Carbonic Anhydrase Inhibitor (CAI)","mechanism":"Blocks carbonic anhydrase in the renal tubule, decreasing bicarbonate secretion and reducing cerebrospinal fluid and intracranial pressure","indications":["Idiopathic intracranial hypertension","Glaucoma","Heart failure","Altitude sickness","Epilepsy"],"contraindications":["Hypersensitivity","Hyponatremia","Hypokalemia","Hepatic disease"],"interactions":["Ritonavir","Indinavir","Amiodarone","Cyclosporine","Quinidine"],"education":["Monitor for symptoms of cerebral edema and intracranial hypertension","Monitor for metabolic acidosis and electrolyte imbalances"] },
{"id":"rn-084","scope":["RN"],"name":{"generic":"Mannitol","brand":["Osmitrol"]},"class":"Osmotic diuretic","mechanism":"Causes osmosis from intracellular to extracellular fluid, drawing water out of the brain parenchyma into the intravascular space","indications":["Increased intracranial pressure and cerebral edema","Increased intraocular pressure"],"contraindications":["Hypersensitivity","Anuria","Severe hypovolemia","Preexisting pulmonary edema","Active intracranial bleeding except during craniotomy"],"interactions":["Aminoglycosides","Cyclosporine","Digoxin","Other diuretics"],"education":["Monitor for symptoms of cerebral edema and intracranial hypertension","Monitor for metabolic acidosis and electrolyte imbalances"] }
{"id":"rn-085","scope":["RN"],"name":{"generic":"Amitriptyline","brand":["Elavil"]},"class":"Tricyclic antidepressant (TCA)","mechanism":"Blocks the reuptake of norepinephrine and serotonin at the presynaptic nerve endings","indications":["Major depressive disorder","Primary insomnia","Anxiety","Chronic pain syndromes"],"contraindications":["Children <12 years","Recent myocardial infarction","Uncompensated heart failure","Cardiac dysrhythmia"],"interactions":["Tramadol","Anticholinergic agents","Fluvoxamine","Phenothiazines","Haloperidol","MAOIs","Calcium channel blockers","Beta blockers","Digoxin","CNS depressants"],"education":["Anticholinergic effects: blurred vision, dry mouth, constipation, urinary retention","Decreases seizure threshold","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]},
{"id":"rn-086","scope":["RN"],"name":{"generic":"Citalopram","brand":["Celexa"]},"class":"Selective serotonin reuptake inhibitor (SSRI)","mechanism":"Selectively blocks neuronal reuptake of serotonin; adaptive cellular changes occur with prolonged blockade","indications":["Major depressive disorder"],"contraindications":["Increased risk for bleeding"],"interactions":["Tramadol","MAOIs","Warfarin","Aspirin","NSAIDs"],"education":["Separate MAOIs and SSRIs by at least 5 weeks to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]},
{"id":"rn-087","scope":["RN"],"name":{"generic":"Escitalopram","brand":["Lexapro"]},"class":"Selective serotonin reuptake inhibitor (SSRI)","mechanism":"Selectively blocks neuronal reuptake of serotonin; adaptive cellular changes occur with prolonged blockade","indications":["Major depression (≥8 years)","OCD (≥7 years)","GAD","Panic disorder","PMDD","Bulimia nervosa","Bipolar depression (with olanzapine)","Treatment-resistant depression (with olanzapine)"],"contraindications":["Increased risk for bleeding"],"interactions":["Tramadol","MAOIs","Warfarin","Aspirin","NSAIDs"],"education":["Separate MAOIs and SSRIs by at least 5 weeks to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]},
{"id":"rn-088","scope":["RN"],"name":{"generic":"Fluoxetine","brand":["Prozac"]},"class":"Selective serotonin reuptake inhibitor (SSRI)","mechanism":"Selectively blocks neuronal reuptake of serotonin; adaptive cellular changes occur with prolonged blockade","indications":["Major depression (≥8 years)","OCD (≥7 years)","Panic disorder","PMDD","Bulimia nervosa","Bipolar depression (with olanzapine)","Treatment-resistant depression (with olanzapine)"],"contraindications":["Increased risk for bleeding"],"interactions":["Tramadol","MAOIs","Warfarin","Aspirin","NSAIDs"],"education":["Separate MAOIs and SSRIs by at least 5 weeks to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]},
{"id":"rn-089","scope":["RN"],"name":{"generic":"Paroxetine","brand":["Paxil"]},"class":"Selective serotonin reuptake inhibitor (SSRI)","mechanism":"Selectively blocks neuronal reuptake of serotonin; adaptive cellular changes occur with prolonged blockade","indications":["Major depressive disorder","OCD","Panic disorder","Social phobia","GAD","PTSD","PMDD"],"contraindications":["Increased risk for bleeding"],"interactions":["Tramadol","MAOIs","Warfarin","Aspirin","NSAIDs"],"education":["Separate MAOIs and SSRIs by at least 5 weeks to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]},
{"id":"rn-090","scope":["RN"],"name":{"generic":"Sertraline","brand":["Zoloft"]},"class":"Selective serotonin reuptake inhibitor (SSRI)","mechanism":"Selectively blocks neuronal reuptake of serotonin; adaptive cellular changes occur with prolonged blockade","indications":["Major depression","PMDD","OCD","PTSD","Social anxiety disorder","Panic disorder"],"contraindications":["Increased risk for bleeding"],"interactions":["Tramadol","MAOIs","Warfarin","Aspirin","NSAIDs"],"education":["Separate MAOIs and SSRIs by at least 5 weeks to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]},
{"id":"rn-091","scope":["RN"],"name":{"generic":"Venlafaxine","brand":["Effexor"]},"class":"Serotonin-norepinephrine reuptake inhibitor (SNRI)","mechanism":"Powerful blockade of norepinephrine and serotonin reuptake with weak dopamine reuptake blockade","indications":["Major depressive disorder","Panic disorder","Social phobia","Generalized anxiety disorder"],"contraindications":["Hypertension"],"interactions":["MAOIs","Antiplatelet agents","Anticoagulants"],"education":["Separate MAOIs and SNRIs by at least 14 days to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]},
{"id":"rn-092","scope":["RN"],"name":{"generic":"Duloxetine","brand":["Cymbalta"]},"class":"Serotonin-norepinephrine reuptake inhibitor (SNRI)","mechanism":"Powerful blockade of norepinephrine and serotonin reuptake with weak dopamine reuptake blockade","indications":["Major depressive disorder","Diabetic peripheral neuropathic pain","Fibromyalgia","Generalized anxiety disorder","Social anxiety","Panic disorder","Chronic musculoskeletal pain","Pediatric depression","Pediatric GAD","Pediatric fibromyalgia"],"contraindications":["Hypertension"],"interactions":["MAOIs","Antiplatelet agents","Anticoagulants"],"education":["Separate MAOIs and SNRIs by at least 14 days to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]}, 
{"id":"rn-093","scope":["RN"],"name":{"generic":"Levomilnacipran","brand":["Fetzima"]},"class":"Serotonin-norepinephrine reuptake inhibitor (SNRI)","mechanism":"Powerful blockade of norepinephrine and serotonin reuptake with weak dopamine reuptake blockade","indications":["Major depressive disorder"],"contraindications":["Hypertension"],"interactions":["MAOIs","Antiplatelet agents","Anticoagulants"],"education":["Separate MAOIs and SNRIs by at least 14 days to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]},
{"id":"rn-094","scope":["RN"],"name":{"generic":"Bupropion hydrochloride","brand":["Wellbutrin"]},"class":"Norepinephrine-dopamine reuptake inhibitor (NDRI)","mechanism":"Inhibits the reuptake of dopamine, norepinephrine, and serotonin","indications":["Depression","Seasonal affective disorder","Smoking cessation"],"contraindications":["Hypersensitivity","Seizure disorders","Conditions that lower seizure threshold (anorexia nervosa, bulimia nervosa, alcohol or substance withdrawal)"],"interactions":["Sertraline","Fluoxetine","Paroxetine","MAOIs within 14 days"],"education":["Separate MAOIs and NDRIs by at least 14 days to prevent serotonin syndrome","can take 2 weeks to see effects and 4-6 weeks for full therapeutic effects"]}, 
{"id":"rn-095","scope":["RN"],"name":{"generic":"Phenelzine sulfate","brand":["Nardil"]},"class":"Monoamine oxidase inhibitor (MAOI)","mechanism":"Irreversibly binds to the MAO-A enzyme","indications":["Major depressive disorder"],"contraindications":["Severe hepatic disease","Pheochromocytoma","Congestive heart failure","Hypersensitivity"],"interactions":["Other antidepressants","Vasoconstrictors","Sympathomimetics (amphetamines, dextromethorphan, diet pills)","Opioids","Insulin"],"education":["NDRI, SNRI, and SSRI must be stopped prior to starting MAOI","Therapeutic effects may take 2 weeks; full effect 4–6 weeks"]},
{"id":"rn-096","scope":["RN"],"name":{"generic":"Selegiline hydrochloride","brand":["Emsam"]},"class":"Monoamine oxidase inhibitor (MAOI)","mechanism":"Irreversibly binds to the MAO-A enzyme","indications":["Major depressive disorder"],"contraindications":["Severe hepatic disease","Pheochromocytoma","Congestive heart failure","Hypersensitivity"],"interactions":["Other antidepressants","Vasoconstrictors","Sympathomimetics (amphetamines, dextromethorphan, diet pills)","Opioids","Insulin"],"education":["NDRI, SNRI, and SSRI must be stopped prior to starting MAOI","Rotate transdermal patch site","Therapeutic effects may take 2 weeks; full effect 4–6 weeks"]},
{"id":"rn-097","scope":["RN"],"name":{"generic":"Mirtazapine","brand":["Remeron"]},"class":"Tetracyclic antidepressant","mechanism":"Blocks presynaptic alpha-2 adrenergic receptors increasing norepinephrine and serotonin release and blocks histamine-1 receptors","indications":["Major depressive disorder"],"contraindications":["Hypersensitivity"],"interactions":["MAOIs","Benzodiazepines","Opioids","Antihistamines"],"education":["Stop MAOI prior to initiation","Therapeutic effects may begin in 2 weeks; full effect in 4–6 weeks"]},
{"id":"rn-098","scope":["RN"],"name":{"generic":"Trazodone hydrochloride","brand":["Desyrel"]},"class":"Serotonin antagonist and reuptake inhibitor (SARI)","mechanism":"Blocks the reuptake of serotonin at the presynaptic nerve membrane","indications":["Sedation","Sleep disorders","Depression"],"contraindications":["Hypersensitivity"],"interactions":["MAOIs","Benzodiazepines","Opioids","Antihistamines"],"education":["Stop MAOI prior to initiation","Therapeutic effects may begin in 2 weeks; full effect in 4–6 weeks"]},
{"id":"rn-099","scope":["RN"],"name":{"generic":"Vortioxetine","brand":["Trintellix"]},"class":"Serotonin modulator and stimulator (SMS)","mechanism":"Inhibits the serotonin transporter increasing serotonin concentration in the synaptic cleft","indications":["Major depressive disorder"],"contraindications":["Hypersensitivity"],"interactions":["MAOIs","Benzodiazepines","Opioids","Antihistamines"],"education":["Stop MAOI prior to initiation","Therapeutic effects may begin in 2 weeks; full effect in 4–6 weeks"]},
{"id":"rn-100","scope":["RN"],"name":{"generic":"Chlorpromazine","brand":["Thorazine"]},"class":"First-generation antipsychotic (typical)","mechanism":"Blocks dopamine-2 receptors preventing postsynaptic dopamine stimulation; exact mechanism in schizophrenia unclear","indications":["Schizophrenia","Psychotic symptoms associated with brain impairment (head trauma, tumor, stroke, alcohol withdrawal, CNS stimulant overdose)"],"contraindications":["Parkinson’s disease","Older adults with dementia","Cardiac arrhythmias or prolonged QTc","Liver damage","Coronary artery disease","Cerebrovascular disease"],"interactions":["CNS depressants","QTc-prolonging antiarrhythmics"],"education":["Risk for extrapyramidal symptoms"]},
{"id":"rn-101","scope":["RN"],"name":{"generic":"Fluphenazine","brand":["Prolixin"]},"class":"First-generation antipsychotic (typical)","mechanism":"Blocks dopamine-2 receptors preventing postsynaptic dopamine stimulation; exact mechanism in schizophrenia unclear","indications":["Schizophrenia","Psychotic symptoms associated with brain impairment (head trauma, tumor, stroke, alcohol withdrawal, CNS stimulant overdose)"],"contraindications":["Parkinson’s disease","Older adults with dementia","Cardiac arrhythmias or prolonged QTc","Liver damage","Coronary artery disease","Cerebrovascular disease"],"interactions":["CNS depressants","QTc-prolonging antiarrhythmics"],"education":["Risk for extrapyramidal symptoms"]},
{"id":"rn-102","scope":["RN"],"name":{"generic":"Haloperidol","brand":["Haldol"]},"class":"First-generation antipsychotic (typical)","mechanism":"Blocks dopamine-2 receptors preventing postsynaptic dopamine stimulation; exact mechanism in schizophrenia unclear","indications":["Schizophrenia","Psychotic symptoms associated with brain impairment (head trauma, tumor, stroke, alcohol withdrawal, CNS stimulant overdose)"],"contraindications":["Parkinson’s disease","Older adults with dementia","Cardiac arrhythmias or prolonged QTc","Liver damage","Coronary artery disease","Cerebrovascular disease"],"interactions":["CNS depressants","QTc-prolonging antiarrhythmics"],"education":["Risk for extrapyramidal symptoms"]}
  
]
